文献速递肾小球疾病

尿液CD80可区分肾小球疾病类型并反映疾病活动

Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity.
PubMed 文献 · Kidney Int Rep · 2020-08-14

研究验证了尿液CD80酶联免疫吸附试验(ELISA)在多种肾病综合征患者中的应用。结果显示,尿液CD80/肌酐值在微小病变型肾病(MCD)中最高,可区分MCD与其他肾病综合征类型,且在MCD和局灶节段性肾小球硬化(FSGS)复发时较缓解时升高。

要点

  • 尿液CD80/肌酐值在MCD中最高,有助于鉴别MCD与其他肾小球疾病。
  • CD80浓度在蛋白尿患者中独立于蛋白尿水平,提示非特异性滤过无关。
  • MCD和FSGS复发时尿液CD80/肌酐值显著高于缓解时。

核心结论

  • 尿液CD80水平可区分MCD与其他肾病综合征类型,并反映疾病活动。

研究设计与样本

  • 研究纳入Mayo Clinic 307例和NEPTUNE 104例患者,包括MCD、FSGS、狼疮肾炎、IgA肾病、膜性肾病、常染色体显性多囊肾病、糖尿病肾病、脓尿及对照。
  • 使用改良的商业CD80 ELISA进行尿液分析验证。

主要发现

  • 尿液CD80/肌酐值在MCD中最高(139 ng/g),显著高于对照(36 ng/g,P<0.01)。
  • 糖尿病肾病伴蛋白尿>2时CD80/肌酐值较对照升高(63 ng/g vs 36 ng/g,P=0.03)。
  • 在蛋白尿患者中,CD80浓度独立于蛋白尿水平。
  • MCD和FSGS复发时CD80/肌酐值高于缓解时(P<0.0001)。

关键数值与推荐

  • 尿液CD80/肌酐值(中位数):对照36 ng/g,MCD 139 ng/g,狼疮肾炎90 ng/g,FSGS 66 ng/g,糖尿病肾病63 ng/g,膜性肾病69 ng/g,IgA肾病19 ng/g,常染色体显性多囊肾病42 ng/g,脓尿31 ng/g。

临床怎么用

  • 尿液CD80或可作为无创生物标志物,辅助鉴别MCD与其他肾病综合征,并监测疾病活动。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Heterogeneity of nephrotic diseases and a lack of validated biomarkers limits interventions and reduces the ability to examine outcomes. Urinary CD80 is a potential biomarker for minimal change disease (MCD) steroid-sensitive nephrotic syndrome (NS). We investigated and validated a CD80 enzyme-linked immunosorbent assay (ELISA) in urine in a large cohort with a variety of nephrotic diseases. METHODS: A commercial CD80 ELISA was enhanced and analytically validated for urine. Patients were from Mayo Clinic (307) and Nephrotic Syndrome Study Network Consortium (NEPTUNE; 104) as follows: minimal change disease (MCD, 56), focal segmental glomerulosclerosis (FSGS, 92), lupus nephritis (LN, 25), IgA nephropathy (IgAN, 20), membranous nephropathy (MN, 49), autosomal dominant polycystic kidney disease (ADPKD, 10), diabetic nephropathy (DN; 106), pyuria (19), and controls (34). Analysis was by Kruskal-Wallis test, generalized estimating equation (GEE) models, and receiver operating characteristic (AUC) curve. RESULTS: Urinary CD80/creatinine values were highest in MCD compared to other glomerular diseases and were increased in DN with proteinuria >2 compared to controls (control = 36 ng/g; MCD = 139 ng/g, P < 0.01; LN = 90 ng/g, P < 0.12; FSGS = 66 ng/g, P = 0.18; DN = 63, P = 0.03; MN = 69 ng/g, P = 0.33; ng/g, P = 0.07; IgA = 19 ng/g, P = 0.09; ADPKD = 42, P = 0.36; and pyuria 31, P = 0.20; GEE, median, P vs. control). In proteinuric patients, CD80 concentration appears to be independent of proteinuria levels, suggesting that it is unrelated to nonspecific passage across the glomeruli. CD80/creatinine values were higher in paired relapse versus remission cases of MCD and FSGS (P < 0.0001, GEE). CONCLUSION: Using a validated ELISA, urinary CD80 levels discriminate MCD from other forms of NS (FSGS, DN, IgA, MN) and primary from secondary FSGS.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Gonzalez Guerrico AM, Lieske J, Klee G, et al. Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity. Kidney Int Rep. 2020. PMID: 33163723. doi:10.1016/j.ekir.2020.08.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。